Polen Focus Growth Portfolio fell 17.27% net in Q1 2026, underperforming the Index by 7.49 percentage points as the strategy remained under pressure. Starbucks was the top contributor on signs that CEO Brian Nicol's turnaround plan is gaining traction. The portfolio added Lam Research, Meta and Rollins, while exiting Abbott Laboratories, Adobe, Boston Scientific, Paycom and Intuit.
The portfolio action reads like a classic late-cycle de-risking from lower-quality compounders into more strategic, platform-level winners. Exiting several healthcare and software names while adding LRCX and META suggests the manager is leaning into businesses with stronger operating leverage and clearer AI/data-center secular tailwinds, which can outperform if macro growth stabilizes and capex stays elevated. The hidden risk is that this is happening after a drawdown, so any continued factor pressure on long-duration growth could force further multiple compression before fundamentals reassert. SBUX stands out as the only meaningful positive outlier, and the second-order implication is more about management credibility than near-term earnings. If the turnaround is genuinely inflecting, the market will start assigning a lower probability of permanent share loss, which can expand multiple faster than same-store sales improve. That makes the name a potential sentiment trade: modest fundamental change can create outsized rerating if positioning remains skeptical. The sales in ABT, ADBE, BSX, and INTU likely reflect a judgment that consensus durability has become too expensive relative to upside. In software, the risk is not just slower demand, but budget consolidation around fewer strategic vendors, which can leave “good but not dominant” names in a valuation trap for multiple quarters. In medtech/diagnostics, any procurement softness or procedure deferral tends to show up with a lag, so these exits may be early rather than wrong if growth re-accelerates into 2H26. Contrarian view: the portfolio is likely underappreciating how quickly factor leadership can reverse in a volatile tape. If market breadth improves and rates ease, the abandoned names with recurring revenue and high margins could rebound faster than expected because they are now out of favor and less owned. The best tell over the next 1-3 months will be whether capital continues rotating into AI infrastructure and consumer turnaround names, or whether this is just a brief style rebound inside a broader de-rating of growth.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately negative
Sentiment Score
-0.30
Ticker Sentiment
